Viewing Study NCT04836494


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2025-12-27 @ 11:46 PM
Study NCT ID: NCT04836494
Status: TERMINATED
Last Update Posted: 2023-12-21
First Post: 2021-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia
Sponsor: CoA Therapeutics, Inc., a BridgeBio company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module